Clinical

The Return Of The J&J Vaccine

The one-dosage Johnson and Johnson vaccine has been stirring controversy about blood clotting. Since then, many states in the United States temporarily paused the distribution of this company’s vaccine. Within days, the distribution will resume with an added label stating a rare blood-clotting disorder that can occur among young women. Although some European restricted a similar vaccine for certain ages and gender, the F.D.A went against that decision in the United States. However, vaccination sites will provide information on the disorder. Although the risk of contracting this disorder is small, there is still a small chance of death, which should not happen with a vaccine.

“At an advisory panel meeting about the blood-clotting issue on Friday, the C.D.C. reported that it had identified a total of 15 cases, including three deaths”

From the New York Times article, “J.&.J. Vaccine Will Be Available Again Soon”

Why are they bringing it back if it is dangerous?

The uniqueness of Johnson & Johnson’s vaccine is that it only requires one dose unlike Pfizer and Moderna. There are people that are afraid of needles or have ptsd where one shot would be much better than two. The chances of contracting the disorder are also very rare.

Why is there a slow decline in vaccination rates?

“About 135.8 million people in the United States have received at least one shot of a coronavirus vaccine. But daily doses have fallen by almost 13 percent since last week, from a peak of 3.38 million daily doses on average to about 2.95 million.”

From the New York Times article, “J.&.J. Vaccine Will Be Available Again Soon”

It is hard to decipher what is causing this decrease since it has been decreasing before the Johnson & Johnson situation. One cause could have been from the factory mishap where they combined the doses of two different vaccines. Since then, production and shipment have slowed, but it also led others to become more skeptical about the reliability of the vaccine. There have also been reported cases where men contracted the blood clotting disorder even though it has beens studied to mainly target young women. The condition, which CDC calls “thrombosis” is most likely caused by heparin, a widely known blood thinner. Researching more on if this is directly caused by the Johnson & Johnson vaccine is tricky, and experts are continuing to look deeper as shipment resumes.

Categories: Clinical, Society